The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
Open accessAbstract
Cancer cells adapt their metabolic processes to support rapid proliferation, but less is known about how cancer cells alter metabolism to promote cell survival in a poorly vascularized tumour microenvironment. Here we identify a key role for serine and glycine metabolism in the survival of brain cancer cells within the ischaemic zones of gliomas. In human glioblastoma multiforme, mitochondrial serine hydroxymethyltransferase (SHMT2) and glycine decarboxylase (GLDC) are highly expressed in the pseudopalisading cells that surround necrotic foci. We find that SHMT2 activity limits that of pyruvate kinase (PKM2) and reduces oxygen consumption, eliciting a metabolic state that confers a profound survival advantage to cells in poorly vascularized tumour regions. GLDC inhibition impairs cells with high SHMT2 levels as the excess glycine not metabolized by GLDC can be converted to the toxic molecules aminoacetone and methylglyoxal. Thus, SHMT2 is required for cancer cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondrial serine hydroxymethyltransferase (SHMT2) is required for cancer cells to adapt to the tumor environment.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [60]
In the citing paper
“SHMT2 also plays a role in redox balance.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [127]
In the citing paper
“Additionally, expression of SHMT2 promotes survival in the ischemic tumor microenvironment in glioma.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,719
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Self-citationExploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Cited by
Sorted by citations
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Metabolomics: beyond biomarkers and towards mechanisms
Johnson, C. H., Ivanisevic, J., & Siuzdak, G. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.25 · Cited by 2,829
One-Carbon Metabolism in Health and Disease
Ducker, G. S., & Rabinowitz, J. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.009 · Cited by 2,239
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735
Zong, W., Rabinowitz, J. D., & White, E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.011 · Cited by 1,330
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,238
Serine and one-carbon metabolism in cancer
Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992
Autophagy, Metabolism, and Cancer
White, E., Mehnert, J. M., & Chan, C. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0490 · Cited by 689
Yi, H.-G., Jeong, Y. H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0363-x · Cited by 634
The Two Faces of Reactive Oxygen Species in Cancer
Reczek, C. R., & Chandel, N. S. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041916-065808 · Cited by 602
“Thus, not surprisingly, one-carbon metabolism is upregulated and required for cancer cell proliferation (Kim et al. 2015, Labuschagne et al. 2014, Nilsson et al. 2014, Ye et al. 2014).”
BackgroundA PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
Pacold, M. E., Brimacombe, K. R., Chan, S. H., Rohde, J. M., Lewis, C. A., Swier, L. J. Y. M., Possemato, R., Chen, W. W., Sullivan, L. B., Fiske, B. P., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2070 · Cited by 553
Self-citationGlioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Gimple, R. C., Bhargava, S., Dixit, D., & Rich, J. N. (2019) · Genes & Development · doi:10.1101/gad.324301.119 · Cited by 514
The role of ubiquitination and deubiquitination in cancer metabolism
Sun, T., Liu, Z., & Yang, Q. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01262-x · Cited by 523
One-carbon metabolism in cancer
Newman, A. C., & Maddocks, O. D. K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.118 · Cited by 525
Metabolism of Amino Acids in Cancer
Wei, Z. C., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 456
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406
Self-citationReversal of cytosolic one-carbon flux compensates for loss of the mitochondrial folate pathway
Ducker, G. S., Chen, L., Morscher, R. J., Ghergurovich, J. M., Esposito, M., Teng, X., Kang, Y., & Rabinowitz, J. D. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.016 · Cited by 419
The importance of serine metabolism in cancer
Mattaini, K. R., Sullivan, M. R., & Heiden, M. G. V. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201604085 · Cited by 423
Methionine is a metabolic dependency of tumor-initiating cells
Wang, Z., Yip, L. Y., Lee, J. H. J., Wu, Z., Chew, H. Y., Chong, P. K. W., Teo, C. C., Ang, H. Y.-K., Peh, K. L. E., Yuan, J. X., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0423-5 · Cited by 431
Semenza, G. L. (2016) · The EMBO Journal · doi:10.15252/embj.201695204 · Cited by 380
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Jones, C., Karajannis, M. A., Jones, D., Kieran, M. W., Monje, M., Baker, S. J., Becher, O. J., Cho, Y., Gupta, N. M., Hawkins, C. E., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now101 · Cited by 372
Functional metabolomics: from biomarker discovery to metabolome reprogramming
Peng, B., Li, H., & Peng, X. (2015) · Protein & Cell · doi:10.1007/s13238-015-0185-x · Cited by 356
Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets
Bi, J., Chowdhry, S., Wu, S., Zhang, W., Masui, K., & Mischel, P. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0226-5 · Cited by 359
Metabolic Reprogramming in Glioma
Strickland, M., & Stoll, E. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00043 · Cited by 357
Dixon, S. J. (2017) · Immunological Reviews · doi:10.1111/imr.12533 · Cited by 314
Targeting amino acid metabolism for cancer therapy
Lukey, M. J., Katt, W. P., & Cerione, R. A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.12.003 · Cited by 293
Agnihotri, S., & Zadeh, G. M. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov125 · Cited by 302
Mitochondrial translation requires folate-dependent tRNA methylation
Morscher, R. J., Ducker, G. S., Li, H., Mayer, J., Gitai, Z., Sperl, W., & Rabinowitz, J. D. (2018) · Nature · doi:10.1038/nature25460 · Cited by 281
The ins and outs of serine and glycine metabolism in cancer
Geeraerts, S. L., Heylen, E., Keersmaecker, K. D., & Kampen, K. R. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00329-9 · Cited by 258
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
Yang, X. P., Wang, Z., Li, X., Liu, B., Liu, M., Liu, L., Chen, S., Ren, M., Wang, Y., Yu, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1912 · Cited by 233
Serine, glycine and one‑carbon metabolism in cancer (Review)
Pan, S., Fan, M., Liu, Z., Li, X., & Wang, H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5158 · Cited by 227
Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225
Formate metabolism in health and disease
Pietzke, M., Meiser, J., & Vazquez, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.012 · Cited by 218
TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway
Zheng, J., Liu, X., Xue, Y., Gong, W., Ma, J., Xi, Z., Que, Z., & Liu, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0422-2 · Cited by 216
The Diverse Functions of Non-Essential Amino Acids in Cancer
Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213
An expanded universe of cancer targets
Hahn, W. C., Bader, J. S., Braun, T. P., Califano, A., Clemons, P. A., Druker, B. J., Ewald, A. J., Fu, H., Jagu, S., Kemp, C. J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.020 · Cited by 213
Minton, D. R., Nam, M., McLaughlin, D. J., Shin, J., Bayraktar, E. C., Alvarez, S., Sviderskiy, V. O., Papagiannakopoulos, T. Y., Sabatini, D. M., Birsoy, K., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.024 · Cited by 192
Self-citationHDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2
Cao, J., Sun, L., Aramsangtienchai, P., Spiegelman, N. A., Zhang, X., Huang, W., Seto, E., & Lin, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815365116 · Cited by 189
Famine versus feast: understanding the metabolism of tumors in vivo
Mayers, J. R., & Heiden, M. G. V. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.01.004 · Cited by 190
Novel therapeutic targets on the horizon for lung cancer
Tan, W.-L., Jain, A., Takano, A. M., Newell, E. W., Iyer, N. G., Lim, W., Tan, E.-H., Zhai, W., Hillmer, A. M., Tam, W. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30123-1 · Cited by 185
Cassim, S., Vučetić, M., Ždralević, M., & Pouysségur, J. (2020) · Cancers · doi:10.3390/cancers12051119 · Cited by 183
Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance
Noch, E., Ramakrishna, R. R., & Magge, R. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.04.022 · Cited by 178
Serine and Functional Metabolites in Cancer
Newman, A. C., & Maddocks, O. D. K. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.05.001 · Cited by 168
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
Shuvalov, O., Petukhov, A., Daks, A., Fedorova, O., Vasileva, E., & Barlev, N. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15053 · Cited by 168
Targeting MTHFD2 in acute myeloid leukemia
Pikman, Y., Puissant, A., Alexe, G., Furman, A. A., Chen, L. M., Frumm, S. M., Ross, L. S., Fenouille, N., Bassil, C. F., Lewis, C. A., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151574 · Cited by 157
Li, S., Swanson, S. K., Gogol, M., Florens, L. A., Washburn, M. P., Workman, J. L., & Suganuma, T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.024 · Cited by 160
Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
Zhou, W., & Wahl, D. R. (2019) · Cancers · doi:10.3390/cancers11091231 · Cited by 152
Cancer’s Fuel Choice: New Flavors for a Picky Eater
DeNicola, G. M., & Cantley, L. C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.018 · Cited by 149
Label-Free Neurosurgical Pathology with Stimulated Raman Imaging
Lu, F., Calligaris, D., Olubiyi, O. I., Norton, I. H., Yang, W., Santagata, S., Xie, X. S., Golby, A. J., & Agar, N. Y. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0270 · Cited by 149
Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
Neagu, M. T., Constantin, C., Popescu, I., Zipeto, D., Tzanakakis, G. N., Nikitovic, D., Fenga, C., Stratakis, C. A., Spandidos, D. A., & Tsatsakis, A. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00348 · Cited by 151
Metabolic regulation of species-specific developmental rates
Díaz-Cuadros, M., Miettinen, T. P., Skinner, O. S., Sheedy, D., Díaz‐García, C. M., Gapon, S., Hubaud, A., Yellen, G., Manalis, S. R., Oldham, W. M., et al. (2023) · Nature · doi:10.1038/s41586-022-05574-4 · Cited by 152
Nicotinamide metabolism regulates glioblastoma stem cell maintenance
Jung, J., Kim, L. J. Y., Wang, X., Wu, Q., Sanvoranart, T., Hubert, C. G., Prager, B. C., Wallace, L. C., Jin, X., Mack, S. C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90019 · Cited by 145
Zheng, X., Boyer, L. F., Jin, M., Kim, Y., Fan, W., Bardy, C., Berggren, W. T., Evans, R. M., Gage, F. H., & Hunter, T. R. (2016) · eLife · doi:10.7554/elife.13378 · Cited by 139
Metabolic requirements for cancer cell proliferation
Keibler, M. A., Wasylenko, T. M., Kelleher, J. K., Iliopoulos, O., Heiden, M. G. V., & Stephanopoulos, G. N. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0156-6 · Cited by 141
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Gimple, R. C., Yang, K., Halbert, M. E., Agnihotri, S., & Rich, J. N. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00486-x · Cited by 148
Targeting metabolic reprogramming in KRAS-driven cancers
Kawada, K., Toda, K., & Sakai, Y. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1156-4 · Cited by 140
Metabolic Reprogramming in Brain Tumors
Venneti, S., & Thompson, C. B. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044329 · Cited by 139
MERAV: a tool for comparing gene expression across human tissues and cell types
Shaul, Y. D., Yuan, B., Thiru, P., Nutter-Upham, A., McCallum, S., Lanzkron, C., Bell, G. W., & Sabatini, D. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1337 · Cited by 127
Self-citationReprogramming of serine, glycine and one-carbon metabolism in cancer
Li, A. M., & Ye, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165841 · Cited by 127
The complexity of the serine glycine one-carbon pathway in cancer
Reina‐Campos, M., Díaz-Meco, M. T., & Moscat, J. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201907022 · Cited by 125
Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119
Metabolic Regulation of Redox Balance in Cancer
Purohit, V., Simeone, D. M., & Lyssiotis, C. A. (2019) · Cancers · doi:10.3390/cancers11070955 · Cited by 121
Formate: The Neglected Member of One-Carbon Metabolism
Brosnan, M. E., & Brosnan, J. T. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050738 · Cited by 112
Nishimura, T., Nakata, A., Chen, X., Nishi, K., Meguro‐Horike, M., Sasaki, S., Kita, K., Horike, S., Saitoh, K., Kato, K., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0589-1 · Cited by 115
Amino acid management in cancer
Tsun, Z.-Y., & Possemato, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.002 · Cited by 120
Self-citationNewman, A. C., Falcone, M., Uribe, A. H., Zhang, T., Athineos, D., Pietzke, M., Vázquez, A., Blyth, K., & Maddocks, O. D. K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.019 · Cited by 117
Beyond the Warburg effect: How do cancer cells regulate one-carbon metabolism?
Rosenzweig, A., Blenis, J., & Gomes, A. P. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00090 · Cited by 107
Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose Metabolism
Xiao, W., Oldham, W. M., Priolo, C., Pandey, A. K., & Loscalzo, J. (2021) · Circulation Research · doi:10.1161/circresaha.120.318805 · Cited by 109
Leung, K., Pai, Y. J., Chen, Q., Santos, C., Calvani, E., Sudiwala, S., Savery, D., Ralser, M., Gross, S. S., Copp, A. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.072 · Cited by 102
Cancer Metabolism: Fueling More than Just Growth
Lee, N., & Kim, D. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0310 · Cited by 102
Self-citationShiota, M., Naya, M., Yamamoto, T., Hishiki, T., Tani, T., Takahashi, H., Kubo, A., Koike, D., Itoh, M., Ohmura, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03899-1 · Cited by 101
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 97
Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma
Jung, J., Zhang, Y., Celiku, O., Zhang, W., Song, H., Williams, B. J., Giles, A. J., Rich, J. N., Abounader, R., Gilbert, M. R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0198 · Cited by 97
Libby, C. J., Tran, A. N., Scott, S. E., Griguer, C. E., & Hjelmeland, A. B. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.01.004 · Cited by 91
Serine-dependent redox homeostasis regulates glioblastoma cell survival
Engel, A. L., Lorenz, N. I., Klann, K., Münch, C., Depner, C., Steinbach, J. P., Ronellenfitsch, M. W., & Luger, A.-L. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0794-x · Cited by 85
Systems biology of oxygen homeostasis
Samanta, D., Prabhakar, N. R., & Semenza, G. L. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1382 · Cited by 85
Structural basis of BRCC36 function in DNA repair and immune regulation
Rabl, J., Bunker, R. D., Schenk, A. D., Cavadini, S., Gill, M. E., Abdulrahman, W., Andrés-Pons, A., Luijsterburg, M. S., Ibrahim, A. F. M., Branigan, E., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.002 · Cited by 84
Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment
Hawk, M. A., & Schafer, Z. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000260 · Cited by 82
Chen, D., Wei, L., Liu, Z., Yang, J. J., Gu, X., Wei, Z. Z., Liu, L., & Yu, S. P. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0635-2 · Cited by 82
The role of glycine in regulated cell death
Weinberg, J. M., Bienholz, A., & Venkatachalam, M. A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2201-6 · Cited by 85
Woo, C. C., Chen, W. C., Teo, X. Q., Radda, G. K., & Lee, P. T. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10415 · Cited by 81
Self-citationAu-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects
Yang, S., Han, G., Chen, Q., Yu, L., Wang, P., Zhang, Q., Dong, J., Zhang, W., & Huang, J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s287523 · Cited by 81
Distinct metabolic hallmarks of WHO classified adult glioma subtypes
Björkblom, B., Wibom, C., Eriksson, M., Bergenheim, A. T., Sjöberg, R. L., Jonsson, P., Brännström, T., Antti, H., Sandström, M., & Melin, B. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac042 · Cited by 78
LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival
Lee, Y. G., Kim, H. W., Nam, Y., Shin, K. J., Lee, Y. J., Park, D. H., Rhee, H., Seo, J. K., & Chae, Y. C. (2021) · Oncogenesis · doi:10.1038/s41389-021-00306-1 · Cited by 79
Establishment of local searching methods for orbitrap-based high throughput metabolomics analysis
Tang, H., Wang, X., Xu, L., Ran, X., Li, X., Chen, L., Zhao, X., Deng, H., & Liu, X. (2016) · Talanta · doi:10.1016/j.talanta.2016.04.051 · Cited by 79
Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer
Dekhne, A. S., Hou, Z., Gangjee, A., & Matherly, L. H. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0423 · Cited by 80
Yu, Q., Tai, Y., Tang, Y. M., Zhao, J., Negi, V., Culley, M. K., Pilli, J., Sun, W., Brugger, K., Mayr, J. A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035889 · Cited by 78
Pinweha, P., Rattanapornsompong, K., Charoensawan, V., & Jitrapakdee, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.005 · Cited by 75
Xiu, Y., & Field, M. S. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa153 · Cited by 75
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Ma, M. C. J., Tadros, S., Bouska, A. C., Heavican, T. B., Yang, H., Deng, Q., Moore, D. Y., Akhter, A., Hartert, K. T., Jain, N. K., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.274258 · Cited by 80
Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox
Samanta, D., & Semenza, G. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1730 · Cited by 76
Serine Supports IL-1β Production in Macrophages Through mTOR Signaling
Chen, S., Xia, Y., He, F., Fu, J., Xin, Z., Deng, B., He, L., Zhou, X., & Ren, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01866 · Cited by 73
Xu, X., Zhang, N., Shu, G., Liu, D., Qi, J., Jin, F., Ji, J., & Du, Y. (2021) · ACS Nano · doi:10.1021/acsnano.1c05891 · Cited by 74
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
Luengo, A., Abbott, K. L., Davidson, S. M., Hosios, A. M., Faubert, B., Chan, S. H., Freinkman, E., Zacharias, L. G., Mathews, T. P., Clish, C. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13419-4 · Cited by 75
Self-citationMuthyalaiah, Y. S., Jonnalagadda, B., John, C. M., & Arockiasamy, S. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10031-x · Cited by 75
Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML
Liu, C., Zou, W., Nie, D., Li, S., Chen, D., Zhou, M., Lai, P., Yang, S., Ji, S., Li, Y., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.004 · Cited by 72
NF-Y activates genes of metabolic pathways altered in cancer cells
Benatti, P., Chiaramonte, M. L., Lorenzo, M., Hartley, J. A., Hochhauser, D., Gnesutta, N., Mantovani, R., Imbriano, C., & Dolfini, D. (2015) · Oncotarget · doi:10.18632/oncotarget.6453 · Cited by 72
Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth
Mukha, D., Fokra, M., Feldman, A., Sarvin, B., Sarvin, N., Nevo-Dinur, K., Besser, E., Hallo, E., Aizenshtein, E., Schug, Z. T., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.006 · Cited by 69
Liu, R., Zeng, L.-W., Gong, R., Yuan, F., Shu, H.-B., & Li, S. (2021) · Nature Communications · doi:10.1038/s41467-021-24321-3 · Cited by 67
Costa‐Machado, L. F., & Fernández-Marcos, P. J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1634953 · Cited by 66
Metadata
- Authors
- Kim, D., Fiske, B. P., Birsoy, K., Freinkman, E., Kami, K., Possemato, R. L., Chudnovsky, Y., Pacold, M. E., Chen, W. W., Cantor, J. R., Shelton, L. M., Gui, D. Y., Kwon, M., Ramkissoon, S. H., Ligon, K. L., Kang, S. W., Snuderl, M., Vander Heiden, M. G., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Human Metabolome Technologies, Inc. (Japan) (JP)
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- NYU Langone Health (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Venue
- Nature
- Published
- 2015-04
- Volume
- 520
- Issue
- 7547
- Pages
- 363-367
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4533874
- OpenAlex
- W1993238514
- Cited by
- 368
- References
- 44
- Citations by year
- 2026: 25 · 2025: 22 · 2024: 21 · 2023: 28 · 2022: 41 · 2021: 42 · 2020: 25 · 2019: 39 · 2018: 34 · 2017: 30 · 2016: 42 · 2015: 18
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Radboud Repository (Radboud University) (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (5-P30-CA14051, CA129105, K99CA168940, CA103866, R01CA103866, R01CA168653, R01CA129105, R00CA168940, P30CA014051)
- National Institute of General Medical Sciences (T32GM007753, T32GM007287)
- National Institute of Allergy and Infectious Diseases (AI-07389, T32AI007389, R37AI047389)
- National Institute of Neurological Disorders and Stroke (K08NS087118)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- SHMT2, glycine decarboxylase, glioblastoma, serine metabolism, glycine metabolism, oxygen consumption, PKM2, methylglyoxal, aminoacetone, tumor cell survival, tumor hypoxia
- MeSH terms
- Acetone, Animals, Brain Neoplasms, Cell Survival, Female, Glioblastoma, Glycine, Humans, Ischemia, Necrosis, Oxygen Consumption, Pyruvaldehyde, Pyruvate Kinase, Glycine Hydroxymethyltransferase, Cell Hypoxia, Xenograft Model Antitumor Assays, Cell Line, Tumor, Glycine Dehydrogenase (Decarboxylating), Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review